Symbol | Company | Weighting |
---|---|---|
GH | GUARDANT HEALTH INC | 3.02% |
ASND | ASCENDIS PHARMA A/S DKK 1.0 ADR | 2.59% |
INSM | INSMED INC | 2.53% |
MRUS | MERUS NV | 2.42% |
MCK | MCKESSON CORP | 2.25% |
ABT | ABBOTT LABORATORIES | 2.21% |
AZN | ASTRAZENECA PLC-ADR | 2.18% |
AXSM | AXSOME THERAPEUTICS INC. | 2.17% |
DXCM | DEXCOM INC | 2.09% |
HCA | HCA HOLDINGS INC | 2.07% |
PEN | PENUMBRA INC | 2.07% |
BSX | BOSTON SCIENTIFIC | 2.06% |
THC | TENET HEALTHCARE CORP | 2.03% |
LLY | ELI LILLY CORP | 2.02% |
SMMT | SUMMIT THERAPEUTICS INC. | 1.98% |
SNY | SANOFI- AVENTIS- ADR | 1.97% |
AMLX | AMYLYX PHARMACEUTICALS INC | 1.96% |
ISRG | INTUITIVE SURGICAL INC | 1.95% |
ALC | ALCON INC | 1.95% |
NAMS | NEWAMSTERDAM PHARMA CO NV | 1.93% |
SYK | STRYKER CORP | 1.91% |
ELV | ELEVANCE HEALTH INC | 1.91% |
RMD | RESMED INC | 1.89% |
NBIX | NEUROCRINE BIOSCIENCES INC | 1.87% |
MOH | MOLINA HEALTHCARE INC | 1.85% |
ARGX | ARGENX SE ADR | 1.80% |
ZTS | ZOETIS INC | 1.77% |
CI | THE CIGNA GROUP | 1.75% |
BMRN | BIOMARIN PHARAMCEUTICAL INC | 1.73% |
ARWR | ARROWHEAD PHARMACEUTICALS INC | 1.68% |
GEHC | GE HEALTHCARE TECHNOLOGIES INC | 1.61% |
IDYA | IDEAYA BIOSCIENCES, INC | 1.61% |
NUVL | NUVALENT INC | 1.59% |
BIIB | BIOGEN INC | 1.59% |
ABVX | ABIVAX SA | 1.58% |
MRK | MERCK & CO. NEW | 1.56% |
TMO | THERMO FISHER SCIENTIFIC INC | 1.55% |
TVTX | TRAVERE THERAPEUTICS INC | 1.53% |
RARE | ULTRAGENYX PHARMACEUTICAL INC | 1.53% |
HUM | HUMANA INC | 1.45% |
IMTX | IMMATICS NV | 1.44% |
BDX | BECTON DICKINSON & CO | 1.41% |
CNTA | CENTESSA PHARMACEUTI | 1.41% |
NVO | NOVO NORDISK A/S | 1.38% |
ICLR | ICON PLC | 1.37% |
RVMD | REVOLUTION MEDICINES INC | 1.36% |
TNDM | TANDEM DIABETES CARE INC | 1.36% |
COO | COOPER COS INC | 1.35% |
INSP | INSPIRE MEDICAL SYSTEMS, INC. | 1.33% |
GKOS | GLAUKOS CORPORATION | 1.31% |
REGN | REGENERON PHARMACEUTICALS | 1.29% |
SNDX | SYNDAX PHARMACEUTICALS, INC. | 1.29% |
CYTK | CYTOKINETICS INC | 1.25% |
IMVT | IMMUNOVANT INC | 1.17% |
UNH | UNITEDHEALTH GROUP INC | 0.97% |
EWTX | EDGEWISE THERAPEUTICS | 0.93% |
PCVX | VAXCYTE INC | 0.78% |
GERN | GERON CORP | 0.73% |
ARVN | ARVINAS INC USD | 0.64% |
Read a prospectus and summary prospectus (if available) carefully before investing. It contains the investment objective, risks charges, expenses and the other information, which should be considered carefully before investing. To obtain a prospectus and summary prospectus (if available) click here or call 800.820.0888.
Investing involves risk, including the possible loss of principal.
Guggenheim Investments represents the following affiliated investment management businesses of Guggenheim Partners, LLC: Guggenheim Partners Investment Management, LLC, Security Investors, LLC, Guggenheim Funds Distributors, LLC, Guggenheim Funds Investment Advisors, LLC, Guggenheim Corporate Funding, LLC, Guggenheim Wealth Solutions, LLC, Guggenheim Partners Europe Limited, Guggenheim Partners Japan Limited, GS GAMMA Advisors, LLC, and Guggenheim Private Investments, LLC. Securities offered through Guggenheim Funds Distributors, LLC.
© 2025 Guggenheim Investments. All Rights Reserved.
Research our firm with FINRA Broker Check.
• Not FDIC Insured • No Bank Guarantee • May Lose Value
This website is directed to and intended for use by citizens or residents of the United States of America only. The material provided on this website is not intended as a recommendation or as investment advice of any kind, including in connection with rollovers, transfers, and distributions. Such material is not provided in a fiduciary capacity, may not be relied upon for or in connection with the making of investment decisions, and does not constitute a solicitation of an offer to buy or sell securities. All content has been provided for informational or educational purposes only and is not intended to be and should not be construed as legal or tax advice and/or a legal opinion. Always consult a financial, tax and/or legal professional regarding your specific situation. Investing involves risk, including the possible loss of principal.